We may earn from vendors via affiliate links or sponsorships. This might affect product placement on our site, but not the content of our reviews. See our Terms of Use for details.
AI is becoming part of medical practice, but training doctors to use it without weakening their clinical judgment presents a different challenge.
OpenEvidence and Johns Hopkins Medicine on Oct. 13 announced a strategic collaboration to develop new approaches to medical education and clinical care, focusing on preparing future physicians for AI-assisted practice and helping clinicians apply current medical evidence to individual patients.
The partnership has two main objectives: redesigning physician training for an AI-enabled environment and developing AI systems that connect medical research, patient histories and Johns Hopkins’ clinical practices to support care decisions.
The organizations plan to build adaptive AI systems for medical education while reinforcing core skills such as understanding disease processes, evaluating evidence, clinical reasoning, diagnosis and patient communication.
“Johns Hopkins designed modern medical education around a simple idea: that physicians learn medicine at the bedside, grounded in science and reasoning,” said Sanjay Desai, vice dean for education at Johns Hopkins Medicine.
Clinical AI moves closer to everyday workflows
The clinical component will focus on AI systems that help physicians find relevant medical evidence and apply it in the context of a patient’s history. The goal is to help clinicians assess information faster and make more informed decisions without removing their responsibility for patient care.
Sara Murray, Johns Hopkins Medicine’s chief medical informatics and AI officer, told Fierce Healthcare that the organizations intend to identify high-impact clinical applications, develop solutions that fit existing workflows and evaluate their effects on clinical decisions, care quality and patient outcomes.
The specific capabilities remain under development. Fierce Healthcare also reported that OpenEvidence was not disclosing commercial arrangements, although CEO Daniel Nadler described the partnership as at least a research, development and product collaboration.
The announcement follows OpenEvidence’s other health care partnerships, including agreements with Penn Medicine, Memorial Sloan Kettering Cancer Center and AdventHealth.
More must-read AI coverage
- SS&C Intralinks DealCentre AI vs. Datasite: Which platform is built for the future of dealmaking?
- SS&C Intralinks FundCentre AI vs. Juniper Square: Which platform better supports modern private markets fund managers?
- Why Data, Not Models, Determines AI Success
- The Rise of the AI-Native Factory: How Physical AI Is Transforming Manufacturing
What the partnership could mean for doctors and patients
For medical students, adaptive AI could eventually offer more personalized instruction, identify gaps in clinical experience and provide additional practice where needed. Desai told Fierce Healthcare that AI could also help schools assess competency rather than relying primarily on time spent in training.
For practicing clinicians, systems that connect evidence with patient histories could reduce the effort required to locate relevant guidance. Patients could benefit if those tools help doctors make more informed, individualized decisions.
However, these benefits remain prospective, not demonstrated outcomes of the new partnership. AI recommendations must be evaluated for accuracy, relevance and consistency, while health systems must ensure clinicians retain appropriate oversight.
The partnership’s significance will ultimately depend on whether it produces measurable improvements in physician training and patient care. Making medical knowledge easier to access is useful; helping doctors apply it safely, critically and compassionately is the harder test.
Other news: Google is partnering with Flo Health to combine menstrual cycle tracking with wearable health data and personalized AI insights.